X4 Pharmaceuticals (XFOR) Capital Expenditures (2017 - 2025)

X4 Pharmaceuticals' (XFOR) quarterly Capital Expenditures came in at $41000.0 in Q4 2024, down 55.43% on a QoQ basis from $92000.0 in Q3 2024.

X4 Pharmaceuticals (XFOR) Capital Expenditures (2017 - 2025) Analysis & Trends

X4 Pharmaceuticals (XFOR) has 8 years of Capital Expenditures data on file, last reported at $41000.0 in Q4 2024.

  • Quarterly Capital Expenditures changed N/A year-over-year to $41000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $41000.0 (down 85.61% YoY) and the FY2024 annual result came in at $326000.0, changed N/A from the prior year.
  • Capital Expenditures fell to $41000.0 in Q4 2024, from $92000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.5 million in Q3 2020 to a low of -$690000.0 in Q4 2020.
  • A 5-year average of $133666.7 and a median of $36000.0 in 2022 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2020 — Capital Expenditures jumped 1737.04% — and 2021, when it sank 5611.11%.
  • Tracing XFOR's Capital Expenditures over 5 years: stood at -$690000.0 in 2020, then surged by 101.88% to $13000.0 in 2021, then soared by 161.54% to $34000.0 in 2022, then slumped by 126.47% to -$9000.0 in 2023, then soared by 555.56% to $41000.0 in 2024.
  • The last three Capital Expenditures figures came in at $41000.0 (Q4 2024), $92000.0 (Q3 2024), and $134000.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.29 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 25.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 572,662.23
7 Royalty Pharma 33.72 Bn 35.84 Bn - 251.02 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 34.68 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 6.26 Mn
10 X4 Pharmaceuticals 533.17 Mn 338.08 Mn 7.19 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 500,000.00
Dec 31, 2025 500,000.00
Dec 31, 2024 41,000.00
Dec 31, 2024 41,000.00
Sep 30, 2024 92,000.00
Sep 30, 2024 92,000.00
Jun 30, 2024 134,000.00
Jun 30, 2024 134,000.00
Mar 31, 2024 59,000.00
Mar 31, 2024 59,000.00
Jun 30, 2023 -9,000.00
Jun 30, 2023 -9,000.00
Mar 31, 2023 9,000.00
Mar 31, 2023 9,000.00
Dec 31, 2022 34,000.00
Dec 31, 2022 34,000.00
Sep 30, 2022 9,000.00
Sep 30, 2022 9,000.00
Jun 30, 2022 38,000.00
Jun 30, 2022 38,000.00